Apelin-17 to diagnose idiopathic pulmonary arterial hypertension: A biomarker study

Background: NT-proBNP and GDF-15 are established blood-derived biomarkers for risk assessment in pulmonary hypertension (PH), despite limited sensitivity and specificity. Apelin has a crucial function in endothelial homeostasis, thus it might represent a new biomarker for PH. However, there are nume...

Full description

Bibliographic Details
Main Authors: Vasile Foris, Gabor Kovacs, Alexander Avian, Zoltán Bálint, Philipp Douschan, Bahil Ghanim, Walter Klepetko, Andrea Olschewski, Horst Olschewski
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Physiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphys.2022.986295/full
_version_ 1797961492280115200
author Vasile Foris
Vasile Foris
Gabor Kovacs
Gabor Kovacs
Alexander Avian
Alexander Avian
Zoltán Bálint
Philipp Douschan
Philipp Douschan
Bahil Ghanim
Walter Klepetko
Andrea Olschewski
Andrea Olschewski
Horst Olschewski
Horst Olschewski
author_facet Vasile Foris
Vasile Foris
Gabor Kovacs
Gabor Kovacs
Alexander Avian
Alexander Avian
Zoltán Bálint
Philipp Douschan
Philipp Douschan
Bahil Ghanim
Walter Klepetko
Andrea Olschewski
Andrea Olschewski
Horst Olschewski
Horst Olschewski
author_sort Vasile Foris
collection DOAJ
description Background: NT-proBNP and GDF-15 are established blood-derived biomarkers for risk assessment in pulmonary hypertension (PH), despite limited sensitivity and specificity. Apelin has a crucial function in endothelial homeostasis, thus it might represent a new biomarker for PH. However, there are numerous circulating apelin isoforms, and their potential role in this setting is unknown. This study evaluated different apelin isoforms in PH patients and prospectively evaluated the role of apelin-17 in comparison with NT-proBNP and GDF-15 as diagnostic marker in idiopathic pulmonary arterial hypertension (IPAH).Methods: Based on our pilot study, we performed a power calculation for apelin-13, apelin-17, apelin-36, as predictor of IPAH vs healthy controls. Apelin-17 provided the best discriminatory power, and accordingly, we enrolled n = 31 patients with IPAH and n = 31 matched healthy controls in a prospective study. NT-proBNP and GDF-15 was determined in all patients. ROC curve analysis was performed to assess the diagnostic value of the markers and their combinations.Results: Apelin-17, NT-proBNP, and GDF-15 were significantly elevated in IPAH patients as compared to controls (p < .001). Apelin-17 detected IPAH with a sensitivity of 68% and a specificity of 93% at a cut-off value of >1,480 pg/ml (AUC 0.86, 95%CI:0.76–0.95) as compared to GDF-15 (sensitivity 86%; specificity 72%, AUC 0.81 (95%CI:0.7–0.92)) and NT-proBNP (sensitivity 86%; specificity 72% (AUC 0.85, 95%CI:0.75–0.95)). Combinations of these markers could be used to increase either specificity or sensitivity.Conclusion: Apelin-17 appears to be suitable blood derived diagnostic marker for idiopathic pulmonary arterial hypertension.
first_indexed 2024-04-11T00:59:03Z
format Article
id doaj.art-9b4ebb590a874cb0a61e6b956be28d58
institution Directory Open Access Journal
issn 1664-042X
language English
last_indexed 2024-04-11T00:59:03Z
publishDate 2023-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Physiology
spelling doaj.art-9b4ebb590a874cb0a61e6b956be28d582023-01-04T19:07:13ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2023-01-011310.3389/fphys.2022.986295986295Apelin-17 to diagnose idiopathic pulmonary arterial hypertension: A biomarker studyVasile Foris0Vasile Foris1Gabor Kovacs2Gabor Kovacs3Alexander Avian4Alexander Avian5Zoltán Bálint6Philipp Douschan7Philipp Douschan8Bahil Ghanim9Walter Klepetko10Andrea Olschewski11Andrea Olschewski12Horst Olschewski13Horst Olschewski14Division of Pulmonology, Department of Internal Medicine, Medical University of Graz, Graz, AustriaLudwig Boltzmann Institute for Lung Vascular Research, Graz, AustriaDivision of Pulmonology, Department of Internal Medicine, Medical University of Graz, Graz, AustriaLudwig Boltzmann Institute for Lung Vascular Research, Graz, AustriaDivision of Pulmonology, Department of Internal Medicine, Medical University of Graz, Graz, AustriaInstitute for Medical Informatics, Statistics and Documentation, Medical University of Graz, Graz, AustriaFaculty of Physics, Babes-Bolyai University Cluj-Napoca, Cluj-Napoca, RomaniaDivision of Pulmonology, Department of Internal Medicine, Medical University of Graz, Graz, AustriaLudwig Boltzmann Institute for Lung Vascular Research, Graz, AustriaDivision of General and Thoracic Surgery, University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, AustriaDivision of Thoracic Surgery, Department of Surgery, Medical University of Vienna, Vienna, AustriaLudwig Boltzmann Institute for Lung Vascular Research, Graz, AustriaExperimental Anesthesiology, Department of Anesthesiology and Intensive Care Medicine, Medical University of Graz, Graz, AustriaDivision of Pulmonology, Department of Internal Medicine, Medical University of Graz, Graz, AustriaLudwig Boltzmann Institute for Lung Vascular Research, Graz, AustriaBackground: NT-proBNP and GDF-15 are established blood-derived biomarkers for risk assessment in pulmonary hypertension (PH), despite limited sensitivity and specificity. Apelin has a crucial function in endothelial homeostasis, thus it might represent a new biomarker for PH. However, there are numerous circulating apelin isoforms, and their potential role in this setting is unknown. This study evaluated different apelin isoforms in PH patients and prospectively evaluated the role of apelin-17 in comparison with NT-proBNP and GDF-15 as diagnostic marker in idiopathic pulmonary arterial hypertension (IPAH).Methods: Based on our pilot study, we performed a power calculation for apelin-13, apelin-17, apelin-36, as predictor of IPAH vs healthy controls. Apelin-17 provided the best discriminatory power, and accordingly, we enrolled n = 31 patients with IPAH and n = 31 matched healthy controls in a prospective study. NT-proBNP and GDF-15 was determined in all patients. ROC curve analysis was performed to assess the diagnostic value of the markers and their combinations.Results: Apelin-17, NT-proBNP, and GDF-15 were significantly elevated in IPAH patients as compared to controls (p < .001). Apelin-17 detected IPAH with a sensitivity of 68% and a specificity of 93% at a cut-off value of >1,480 pg/ml (AUC 0.86, 95%CI:0.76–0.95) as compared to GDF-15 (sensitivity 86%; specificity 72%, AUC 0.81 (95%CI:0.7–0.92)) and NT-proBNP (sensitivity 86%; specificity 72% (AUC 0.85, 95%CI:0.75–0.95)). Combinations of these markers could be used to increase either specificity or sensitivity.Conclusion: Apelin-17 appears to be suitable blood derived diagnostic marker for idiopathic pulmonary arterial hypertension.https://www.frontiersin.org/articles/10.3389/fphys.2022.986295/fullapelin-17NT-proBNPGDF-15blood derived biomarkerdiagnosisidiopathic pulmonary arterial hypertension
spellingShingle Vasile Foris
Vasile Foris
Gabor Kovacs
Gabor Kovacs
Alexander Avian
Alexander Avian
Zoltán Bálint
Philipp Douschan
Philipp Douschan
Bahil Ghanim
Walter Klepetko
Andrea Olschewski
Andrea Olschewski
Horst Olschewski
Horst Olschewski
Apelin-17 to diagnose idiopathic pulmonary arterial hypertension: A biomarker study
Frontiers in Physiology
apelin-17
NT-proBNP
GDF-15
blood derived biomarker
diagnosis
idiopathic pulmonary arterial hypertension
title Apelin-17 to diagnose idiopathic pulmonary arterial hypertension: A biomarker study
title_full Apelin-17 to diagnose idiopathic pulmonary arterial hypertension: A biomarker study
title_fullStr Apelin-17 to diagnose idiopathic pulmonary arterial hypertension: A biomarker study
title_full_unstemmed Apelin-17 to diagnose idiopathic pulmonary arterial hypertension: A biomarker study
title_short Apelin-17 to diagnose idiopathic pulmonary arterial hypertension: A biomarker study
title_sort apelin 17 to diagnose idiopathic pulmonary arterial hypertension a biomarker study
topic apelin-17
NT-proBNP
GDF-15
blood derived biomarker
diagnosis
idiopathic pulmonary arterial hypertension
url https://www.frontiersin.org/articles/10.3389/fphys.2022.986295/full
work_keys_str_mv AT vasileforis apelin17todiagnoseidiopathicpulmonaryarterialhypertensionabiomarkerstudy
AT vasileforis apelin17todiagnoseidiopathicpulmonaryarterialhypertensionabiomarkerstudy
AT gaborkovacs apelin17todiagnoseidiopathicpulmonaryarterialhypertensionabiomarkerstudy
AT gaborkovacs apelin17todiagnoseidiopathicpulmonaryarterialhypertensionabiomarkerstudy
AT alexanderavian apelin17todiagnoseidiopathicpulmonaryarterialhypertensionabiomarkerstudy
AT alexanderavian apelin17todiagnoseidiopathicpulmonaryarterialhypertensionabiomarkerstudy
AT zoltanbalint apelin17todiagnoseidiopathicpulmonaryarterialhypertensionabiomarkerstudy
AT philippdouschan apelin17todiagnoseidiopathicpulmonaryarterialhypertensionabiomarkerstudy
AT philippdouschan apelin17todiagnoseidiopathicpulmonaryarterialhypertensionabiomarkerstudy
AT bahilghanim apelin17todiagnoseidiopathicpulmonaryarterialhypertensionabiomarkerstudy
AT walterklepetko apelin17todiagnoseidiopathicpulmonaryarterialhypertensionabiomarkerstudy
AT andreaolschewski apelin17todiagnoseidiopathicpulmonaryarterialhypertensionabiomarkerstudy
AT andreaolschewski apelin17todiagnoseidiopathicpulmonaryarterialhypertensionabiomarkerstudy
AT horstolschewski apelin17todiagnoseidiopathicpulmonaryarterialhypertensionabiomarkerstudy
AT horstolschewski apelin17todiagnoseidiopathicpulmonaryarterialhypertensionabiomarkerstudy